Pairwise comparison between tumor and matching normal tissue in individual patients indicated that KREMEN1 expression is downregulated in a variety of cancer, especially breast, colon, and kidney renal cell carcinomas (Fig. 5a, see Supplementary Table 3 for abbreviations) as previously reported14. This evidence concerns the gene KREMEN1 and neoplasm.